Mobile contingency management as an adjunctive smoking cessation treatment for smokers with posttraumatic stress disorder.
Journal Article (Journal Article)
INTRODUCTION: Smokers with posttraumatic stress disorder (PTSD) smoke at higher prevalence rates and are more likely to relapse early in a quit attempt. Innovative methods are needed to enhance quit rates, particularly in the early quit period. Web-based contingency-management (CM) approaches have been found helpful in reducing smoking among other difficult-to-treat smoker populations but are limited by the need for computers. This pilot study builds on the web-based CM approach by evaluating a smartphone-based application for CM named mobile CM (mCM). METHODS: Following a 2-week training period, 22 smokers with PTSD were randomized to a 4-week mCM condition or a yoked (i.e., noncontingent 4-week mCM condition). All smokers received 2 smoking cessation counseling sessions, nicotine replacement, and bupropion. Participants could earn up to $690 ($530 for mCM, $25.00 for assessments and office visits [up to 5], and $35.00 for equipment return). The average earned was $314.00. RESULTS: Compliance was high during the 2-week training period (i.e., transmission of videos) (93%) and the 4-week treatment period (92%). Compliance rates did not differ by group assignment. Four-week quit rates (verified with CO) were 82% for the mCM and 45% for the yoked controls. Three-month self-report quit rates were 50% in the mCM and 18% in the yoked controls. CONCLUSIONS: mCM may be a useful adjunctive smoking cessation treatment component for reducing smoking among smokers with PTSD, particularly early in a smoking quit attempt.
Full Text
Duke Authors
- Beckham, Jean Crowell
- Calhoun, Patrick Shields
- Dedert, Eric
- Dennis, Paul Anthony
- Moore, Scott Daniel
Cited Authors
- Hertzberg, JS; Carpenter, VL; Kirby, AC; Calhoun, PS; Moore, SD; Dennis, MF; Dennis, PA; Dedert, EA; Beckham, JC
Published Date
- November 2013
Published In
Volume / Issue
- 15 / 11
Start / End Page
- 1934 - 1938
PubMed ID
- 23645606
Pubmed Central ID
- PMC3790624
Electronic International Standard Serial Number (EISSN)
- 1469-994X
Digital Object Identifier (DOI)
- 10.1093/ntr/ntt060
Language
- eng
Conference Location
- England